• 1. Traditional Chinese Medicine of Tianjin University, Tianjin, 300193, P.R.China;
  • 2. Program Office for Cancer Screening in Urban China, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China;
  • 3. Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, P.R.China;
DAI Min, Email: daimin2002@hotmail.com; CHEN Jing, Email: cjshcsyc@126.com
Export PDF Favorites Scan Get Citation

It is potential for N-of-1 trials to evaluate economics of health care, however, it is still in the exploratory stage. With the advantage of accurate estimation of costs and effects, it is beneficial to promote the application of N-of-1 trials for economic evaluation in the era of precision medicine. In this study, we introduce the necessity, feasibility, selection, calculation of indicators and influence factors of N-of-1 trials for economic evaluation, and in order to provide references for researchers to perform related studies.

Citation: ZHAI Jingbo, LI Jiang, SHANG Hongcai, WANG Hui, DAI Min, CHEN Jing. An introduction of economic evaluation of N-of-1 trials. Chinese Journal of Evidence-Based Medicine, 2017, 17(6): 742-744. doi: 10.7507/1672-2531.201701078 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Interpretation of reporting guideline for dose-response meta-analysis——G-Dose Checklist